White paper: The Cardiovascular Benefits of the Virta Treatment

Learn how the Virta Treatment not only delivers type 2 diabetes reversal rates of 60% at one year, but also significantly improves cardiovascular disease risk factors, including blood pressure, inflammation, and obesity.


Download the white paper here.

DOWNLOAD WHITE PAPER

Revolutionary Clinical

Outcomes

94%

OF INSULIN USERS REDUCED
OR ELIMINATED USAGE

1.3%

AVERAGE REDUCTION

IN HBA1C

12%

AVERAGE WEIGHT LOSS

(30 LBS)

Our peer reviewed clinical trial results are causing organizations to rethink their approach to diabetes. At 1 year, most patients see sustained improvements in blood sugar control, medication reduction and elimination, clinically significant weight loss, improved triglycerides, and lowered inflammation.

PATIENT OUTCOMES

Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018. DOI: 10.1007/s13300-018-0373-9

If you are a health plan or benefits leader, a physician, or a potential patient, let's discuss how Virta can help you.



Interested in Learning More?


HOW IT WORKS

LEARN MORE

COMPANY

HAVE QUESTIONS?

© 2018 Virta Health Corp

535 Mission Street, San Francisco, CA 94105

Patent Pending